Histoplasma duboisii

From WikiMD's WELLNESSPEDIA

Histoplasma duboisii is a species of fungus that is pathogenic to humans. It is a member of the genus Histoplasma, which also includes the closely related species Histoplasma capsulatum. H. duboisii is primarily found in Africa and is the causative agent of African histoplasmosis, a disease that can affect both the skin and internal organs.

Taxonomy[edit]

Histoplasma duboisii was first described in 1952 by the Dutch physician A. J. P. Dubois, after whom the species is named. It is classified within the phylum Ascomycota, the largest phylum of fungi, which also includes many other medically important fungi such as Candida albicans and Aspergillus fumigatus.

Morphology[edit]

Like other species in the genus Histoplasma, H. duboisii is a dimorphic fungus, meaning it can exist in two different forms depending on the environmental conditions. In the environment, it grows as a mold with filamentous hyphae. However, when it infects a host organism, it transforms into a yeast form.

Pathogenesis and Clinical Features[edit]

Histoplasma duboisii causes a disease known as African histoplasmosis. This disease is similar to the more common histoplasmosis caused by H. capsulatum, but it tends to cause more severe skin and bone lesions. The fungus is inhaled as spores, which can then disseminate throughout the body. Symptoms can include fever, weight loss, and skin lesions, and the disease can be fatal if not treated.

Diagnosis and Treatment[edit]

Diagnosis of African histoplasmosis is typically made by identifying H. duboisii in tissue samples or by serological tests. Treatment usually involves antifungal medications, such as amphotericin B or itraconazole.

Epidemiology[edit]

Histoplasma duboisii is primarily found in Africa, particularly in West and Central Africa. However, cases have also been reported in other parts of the world, including Europe and the Americas, usually in individuals who have traveled to endemic areas.

See Also[edit]

This article is a stub related to fungus. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.